Amberstone Biosciences

Amberstone Biosciences discovers new immunotherapies through innovative technologies and creative partnerships, develops transformative therapeutic antibodies, and benefits patients with unmet medical needs. Amberstone Biosciences primarily focuses on the research and development of next-generation therapeutic biologics, possesses deep insights in immuno-oncology, and has extensive experience in single-cell assay biology. Amberstone Biosciences is developing in-house antibody programs and advancing the immunotherapy pipelines of biopharmaceutical partners.